Martinez-Gamboa L, Brezinschek HP, Burmester GR, Dorner T: Immunopathologic role of B lymphocytes in rheumatoid arthritis: rationale of B cell-directed therapy. Autoimmun Rev. 2006, 5: 437-442. 10.1016/j.autrev.2006.02.004.
Article
CAS
PubMed
Google Scholar
O'Neill SK, Glant TT, Finnegan A: The role of B cells in animal models of rheumatoid arthritis. Front Biosci. 2007, 12: 1722-1736. 10.2741/2184.
Article
PubMed
Google Scholar
Youinou P, Jamin C, Saraux A: B-cell: a logical target for treatment of rheumatoid arthritis. Clin Exp Rheumatol. 2007, 25: 318-328.
CAS
PubMed
Google Scholar
Eisenberg R, Albert D: B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus. Nat Clin Pract Rheumatol. 2006, 2: 20-27. 10.1038/ncprheum0042.
Article
CAS
PubMed
Google Scholar
Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ: Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003, 48: 2741-2749. 10.1002/art.11223.
Article
PubMed
Google Scholar
Nielen MM, van Schaardenburg D, Reesink HW, Stadt van de RJ, Horst-Bruinsma van der IE, de Koning MH, Habibuw MR, Vandenbroucke JP, Dijkmans BA: Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004, 50: 380-386. 10.1002/art.20018.
Article
PubMed
Google Scholar
Talal N, Grey HM, Zvaifler N, Michalski JP, Daniels TE: Elevated salivary and synovial fluid beta2-microglobulin in Sjogren's syndrome and rheumatoid arthritis. Science. 1975, 187: 1196-1198. 10.1126/science.46621.
Article
CAS
PubMed
Google Scholar
Aho K, Heliovaara M, Knekt P, Reunanen A, Aromaa A, Leino A, Kurki P, Heikkilä R, Palosuo T: Serum immunoglobulins and the risk of rheumatoid arthritis. Ann Rheum Dis. 1997, 56: 351-356. 10.1136/ard.56.6.351.
Article
PubMed Central
CAS
PubMed
Google Scholar
Gottenberg JE, Aucouturier F, Goetz J, Sordet C, Jahn I, Busson M, Cayuela JM, Sibili J, Mariette X: Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome. Ann Rheum Dis. 2007, 66: 23-27. 10.1136/ard.2006.052159.
Article
PubMed Central
CAS
PubMed
Google Scholar
Mackay F, Schneider P, Rennert P, Browning J: BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol. 2003, 21: 231-264. 10.1146/annurev.immunol.21.120601.141152.
Article
CAS
PubMed
Google Scholar
Combe B, Benessiano J, Berenbaum F, Cantagrel A, Daures JP, Dougados M, Fardellone P, Fautrel B, Flipo RM, Goupolle P, Guillemin F, Le Loet X, Logeart I, Mariette X, Meyer O, Ravaud P, Rincheval N, Saraux A, Schaeverbeke T, Sibilia J: The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients. Joint Bone Spine. 2007, 74: 440-445. 10.1016/j.jbspin.2007.06.001.
Article
PubMed
Google Scholar
Emmerich F, Bal G, Barakat A, Milz J, Muhle C, Martinez-Gamboa L, Dörner T, Salama A: High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura. Br J Haematol. 2007, 136: 309-314. 10.1111/j.1365-2141.2006.06431.x.
Article
CAS
PubMed
Google Scholar
Gottenberg JE, Sellam J, Ittah M, Lavie F, Proust A, Zouali H, Sordet C, Sibilia J, Kimberly RP, Mariette X, Miceli-Richard C: No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjogren's syndrome. Arthritis Res Ther. 2006, 8: R30-10.1186/ar1884.
Article
PubMed Central
PubMed
Google Scholar
Novak AJ, Grote DM, Ziesmer SC, Kline MP, Manske MK, Slager S, Witzig TE, Shanafelt T, Call TG, Kay NE, Jelinek DF, Cerhan JR, Gross JA, Harder B, Dillon SR, Ansell SM: Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders. J Clin Oncol. 2006, 24: 983-987. 10.1200/JCO.2005.02.7938.
Article
CAS
PubMed
Google Scholar
Devauchelle-Pensec V, Josseaume T, Samjee I, Dougados M, Combe B, Saraux A: Ability of oblique foot radiographs to detect erosions in early arthritis: results in the ESPOIR cohort. Arthritis Rheum. 2008, 59: 1729-1734. 10.1002/art.24310.
Article
PubMed
Google Scholar
Lavie F, Miceli-Richard C, Ittah M, Sellam J, Gottenberg JE, Mariette X: Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production. Ann Rheum Dis. 2007, 66: 700-703. 10.1136/ard.2006.060772.
Article
PubMed Central
CAS
PubMed
Google Scholar
Vallerskog T, Heimburger M, Gunnarsson I, Zhou W, Wahren-Herlenius M, Trollmo C, Malström V: Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther. 2006, 8: R167-10.1186/ar2076.
Article
PubMed Central
PubMed
Google Scholar
Saraux A, Berthelot JM, Chales G, Le Henaff C, Thorel JB, Hoang S, Valls I, Devauchelle V, Martin A, Baron D, Pennec Y, Botton E, Mary JY, Le Goff P, Youinou P: Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum. 2001, 44: 2485-2491. 10.1002/1529-0131(200111)44:11<2485::AID-ART428>3.0.CO;2-S.
Article
CAS
PubMed
Google Scholar
Helm-van Mil Van der AHM, le Cessie S, van Dongen H, Breedveld FC, Toes REM, Huizinga TWJ: A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis. Arthritis Rheum. 2007, 56: 433-440. 10.1002/art.22380.
Article
PubMed
Google Scholar
Symmons DP, Silman AJ: Aspects of early arthritis. What determines the evolution of early undifferentiated arthritis and rheumatoid arthritis? An update from the Norfolk Arthritis Register. Arthritis Res Ther. 2006, 8: 214-10.1186/ar1979.
Article
PubMed Central
PubMed
Google Scholar
Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G, Rantapää-Dahlqvist S: Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis. 2006, 65: 453-458. 10.1136/ard.2005.041376.
Article
PubMed Central
CAS
PubMed
Google Scholar
Forslind K, Ahlmén M, Eberhardt K, Hafström I, Svensson B, BARFOT Study Group: Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis. 2004, 63: 1090-1095. 10.1136/ard.2003.014233.
Article
PubMed Central
CAS
PubMed
Google Scholar
Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, Kyle RA: Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem. 2002, 48: 1437-1444.
CAS
PubMed
Google Scholar
Kawasaki A, Tsuchiya N, Fukazawa T, Hashimoto H, Tokunaga K: Presence of four major haplotypes in human BCMA gene: lack of association with systemic lupus erythematosus and rheumatoid arthritis. Genes Immun. 2001, 2: 276-279. 10.1038/sj.gene.6363770.
Article
CAS
PubMed
Google Scholar
Cheema GS, Roschke V, Hilbert DM, Stohl W: Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 2001, 44: 1313-1319. 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S.
Article
CAS
PubMed
Google Scholar
Collins CE, Gavin AL, Migone TS, Hilbert DM, Nemazee D, Stohl W: B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels. Arthritis Res Ther. 2006, 8: R6-10.1186/ar1855.
Article
PubMed Central
PubMed
Google Scholar
Tan SM, Xu D, Roschke V, Perry JW, Arkfeld DG, Ehresmann GR, Migone TS, Hilbert DM, Stohl W: Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum. 2003, 48: 982-992. 10.1002/art.10860.
Article
CAS
PubMed
Google Scholar
Bosello S, Youinou P, Daridon C, Tolusso B, Bendaoud B, Pietrapertosa D, Morelli A, Ferraccioli G: Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis. J Rheumatol. 2008, 35: 1256-1264.
CAS
PubMed
Google Scholar
Raza K, Falciani F, Curnow SJ, Ross EJ, Lee CY, Akbar AN, Lord JM, Gordon C, Buckley CD, Salmon M: Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther. 2005, 7: R784-795. 10.1186/ar1733.
Article
PubMed Central
CAS
PubMed
Google Scholar
Xu W, He B, Chiu A, Chadburn A, Shan M, Buldys M, Ding A, Knowles DM, Santini PA, Cerutti A: Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI. Nat Immunol. 2007, 8: 294-303. 10.1038/ni1434.
Article
CAS
PubMed
Google Scholar
Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA: Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol. 2006, 24: 99-146. 10.1146/annurev.immunol.24.021605.090737.
Article
CAS
PubMed
Google Scholar
Seyler TM, Park YW, Takemura S, Bram RJ, Kurtin PJ, Goronzy JJ, Weyand CM: BLyS and APRIL in rheumatoid arthritis. J Clin Invest. 2005, 115: 3083-3092. 10.1172/JCI25265.
Article
PubMed Central
CAS
PubMed
Google Scholar